We are live on ! Find out more
ACM

American Capital Management Portfolio holdings

AUM $1.86B
1-Year Est. Return 20.23%
This Fund
S&P 500
This Quarter Est. Return
+10.19%
1 Year Est. Return
+20.23%
3 Year Est. Return
+63.07%
5 Year Est. Return
+75.1%
10 Year Est. Return
+632.65%
AUM
$3.12B
AUM Growth
+$196M
Cap. Flow
-$52.5M
Cap. Flow %
-1.68%
Top 10 Hldgs %
48.99%
Holding
64
New
Increased
16
Reduced
38
Closed

Top Buys

Rank Stock Value
1
KTOS icon
Kratos Defense & Security Solutions
KTOS
+$19.8M
2
RAMP icon
LiveRamp
RAMP
+$17.6M
3
NEOG icon
Neogen
NEOG
+$5.87M
4
CVLT icon
Commault Systems
CVLT
+$5.23M
5
CRNC icon
Cerence
CRNC
+$4.38M

Top Sells

Rank Stock Value
1
MANH icon
Manhattan Associates
MANH
+$44.4M
2
ICLR icon
Icon
ICLR
+$21.5M
3
CYBR
CyberArk
CYBR
+$8.67M
4
AVAV icon
AeroVironment
AVAV
+$5.84M
5
MEDP icon
Medpace
MEDP
+$5.61M

Sector Composition

Rank Sector Weight
1 Technology 46.98%
2 Healthcare 30.29%
3 Industrials 11.13%
4 Financials 5.84%
5 Consumer Discretionary 3.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYBR
1
DELISTED
CyberArk
CYBR
$215M 6.89%
808,667
-35,003
-4% -$8.67M
AVAV icon
2
AeroVironment
AVAV
$9.45B
$199M 6.37%
1,297,031
-43,721
-3% -$5.84M
FTNT icon
3
Fortinet
FTNT
$117B
$161M 5.16%
2,356,755
-25,304
-1% -$1.68M
MANH icon
4
Manhattan Associates
MANH
$11.4B
$160M 5.14%
640,311
-186,629
-23% -$44.4M
IDXX icon
5
Idexx Laboratories
IDXX
$46.2B
$158M 5.07%
293,153
-9,147
-3% -$5M
MEDP icon
6
Medpace
MEDP
$16.5B
$153M 4.91%
379,161
-15,959
-4% -$5.61M
ICLR icon
7
Icon
ICLR
$12.7B
$148M 4.74%
439,753
-72,975
-14% -$21.5M
NICE icon
8
Nice
NICE
$5.97B
$126M 4.04%
484,092
-7,280
-1% -$1.65M
QLYS icon
9
Qualys
QLYS
$6.35B
$110M 3.51%
656,984
-27,260
-4% -$4.81M
RMD icon
10
ResMed
RMD
$30.7B
$98.4M 3.15%
496,754
-4,797
-1% -$879K
ANSS
11
DELISTED
Ansys
ANSS
$95.2M 3.05%
274,340
-3,583
-1% -$1.21M
GNTX icon
12
Gentex
GNTX
$5.07B
$85.5M 2.74%
2,368,054
-3,210
-0.1% -$111K
FDS icon
13
Factset
FDS
$10.2B
$85.2M 2.73%
187,613
-6,814
-4% -$3.18M
JKHY icon
14
Jack Henry & Associates
JKHY
$11.1B
$81.4M 2.61%
468,688
-101
-0% -$17.2K
CSGP icon
15
CoStar Group
CSGP
$12.3B
$78.6M 2.52%
813,599
-6,498
-0.8% -$559K
CVLT icon
16
Commault Systems
CVLT
$5.61B
$77.3M 2.48%
761,771
+57,796
+8% +$5.23M
VEEV icon
17
Veeva Systems
VEEV
$37.4B
$74.7M 2.4%
322,511
-880
-0.3% -$190K
TECH icon
18
Bio-Techne
TECH
$11.3B
$71.6M 2.29%
1,016,556
+56,464
+6% +$4.04M
CGNX icon
19
Cognex
CGNX
$11.3B
$64.4M 2.06%
1,518,146
+3,265
+0.2% +$127K
RBC icon
20
RBC Bearings
RBC
$18B
$58.9M 1.89%
218,032
-6,176
-3% -$1.67M
GWRE icon
21
Guidewire Software
GWRE
$14.2B
$51.1M 1.64%
438,151
-9,212
-2% -$1.05M
CRL icon
22
Charles River Laboratories
CRL
$12.8B
$49.7M 1.59%
183,300
DXCM icon
23
DexCom
DXCM
$32B
$49.3M 1.58%
355,546
-7,842
-2% -$986K
CGNT icon
24
Cognyte Software
CGNT
$680M
$48M 1.54%
5,801,681
-734
-0% -$5.21K
RAMP icon
25
LiveRamp
RAMP
$2.3B
$44.9M 1.44%
1,300,023
+477,671
+58% +$17.6M

Similar funds

American Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, American Capital Management held 64 positions worth $3.12B, up 6.7% from $2.92B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Trading was light in Q1 2024: portfolio turnover was 0%. American Capital Management opened no new positions and made no exits, leaving the 64-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 47% of assets, down from 47% a quarter earlier, followed by Healthcare and Industrials.

  • American Capital Management added most to Kratos Defense & Security Solutions in Q1 2024, an estimated $19.8M increase.
  • American Capital Management's biggest Q1 2024 reduction was Manhattan Associates, cutting an estimated $44.4M.
  • American Capital Management's ten largest holdings make up 49% of its $3.12B portfolio in Q1 2024.
  • American Capital Management opened 0 new positions and closed 0 in Q1 2024.
  • American Capital Management's portfolio value rose 6.7% quarter-over-quarter to $3.12B.

Based on American Capital Management's 13F filing for Q1 2024, filed 15 May 2024.